Global Clinical Oncology NGS Market Share

Statistics for the 2023 & 2024 Global Clinical Oncology NGS market share, created by Mordor Intelligence™ Industry Reports. Global Clinical Oncology NGS share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Biotechnology Research Bioservices Research Clinical Research Organizations Research Global Clinical Oncology NGS Market Market Share

Market Share of Global Clinical Oncology NGS Industry

The clinical oncology next-generation sequencing (NGS) market is highly competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Illumina, Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Agilent Technologies, Myriad Genetics, Beijing Genomics Institute (BGI), Perkin Elmer.

Clinical Oncology NGS Market Leaders

  1. Illumina, Inc.

  2. Thermo Fisher Scientific

  3. F. Hoffmann-La Roche Ltd.

  4. Agilent Technologies

  5. Myriad Genetics

*Disclaimer: Major Players sorted in no particular order

Picture3.png

Global Clinical Oncology NGS Report Snapshots

Clinical Oncology NGS Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)